Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 4.50M | £ 7.80M | £ 6.00M | £ 6.00M | £ 13.60M |
Total Assets | £ 284.00M | £ 318.20M | £ 238.50M | £ 204.70M | £ 184.10M |
Total Debt | £ 63.60M | £ 81.80M | £ 53.50M | £ 49.30M | £ 45.90M |
Net Debt | £ 59.10M | £ 74.00M | £ 47.50M | £ 43.30M | £ 32.30M |
Total Liabilities | £ 242.50M | £ 279.70M | £ 201.70M | £ 177.10M | £ 156.10M |
Stockholders Equity | £ 41.50M | £ 38.50M | £ 36.80M | £ 27.60M | £ 28.00M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |